Preparation & Measurement Guide

Epitalon 50mg Dosage Protocol

Preparation, measurement, commonly documented protocol ranges, and storage for a Epitalon 50mg vial.

Research use only Educational summary of a commonly documented convention. Not approved for human use.
Vial Size Epitalon 50mg
Preparation 2mL bacteriostatic water
Concentration 25mg/mL after preparation
Documented Convention 5mg daily for 10-20 days

1. Preparation and Measurement

Epitalon 50mg With 2mL of Diluent

Add 2mL of bacteriostatic water to the vial. The resulting concentration is 25mg/mL. On a U-100 syringe, each unit contains 250mcg.

50mg / 2mL = 25mg/mL
1 U-100 unit = 0.01mL = 250mcg

Preparation

  1. Draw 2mL of bacteriostatic water using sterile equipment.
  2. Let the liquid run slowly down the inside wall of the vial.
  3. Gently swirl until dissolved. Do not shake.
  4. Label with the preparation date and refrigerate.

Check the calculation with the peptide calculator.

2. Commonly Documented Schedule

Route commonly described: subcutaneous in circulated protocols. Frequency: once daily for a defined cycle.

Period Documented amount Measurement
Days 1-10 5mg once daily 0.2mL / 20 units
Days 11-20 5mg once daily, when a 20-day convention is documented 0.2mL / 20 units

Vial estimate: One 50mg vial contains approximately 10 documented-size administrations at 5mg.

Practical Notes

  • The table applies only to this vial prepared with exactly 2mL.
  • Record the amount, date, and preparation used.

3. Supplies Needed

  • Epitalon 50mg vial.
  • 2mL of bacteriostatic water per vial.
  • Sterile U-100 syringes.
  • Alcohol swabs.
  • Sharps container.

4. Storage and Handling

  • Keep unopened vials cool, dry, dark, and protected from moisture.
  • After preparation, refrigerate at 2-8 degrees C.
  • Protect from light and avoid repeated freeze-thaw cycles.
  • Do not use material with particles, discoloration, or a damaged seal.

5. Research Context

Epitalon has been examined mainly in cell and animal models involving telomerase, oxidative stress, and aging-related pathways. Human evidence is limited and does not establish a standard protocol.

Epitalon is not an approved therapeutic drug. The 10-20 day table records a commonly circulated convention rather than a validated clinical schedule.

Primary Research and Regulatory References

  1. Epitalon and telomerase activity in human cells
  2. Epitalon experimental aging research

Research Materials

Review Epitalon 50mg Product Information

← Back to Dosage Protocols

Research-use disclaimer: Epitalon 50mg products sold by Vialcrest are intended strictly for laboratory research. They are not intended for human consumption, injection, therapeutic use, medical use, diagnostic use, or veterinary use. This article documents how a commonly circulated or published convention is described for educational comparison. It does not endorse that convention, establish safety or efficacy, or provide medical advice.